DE3872199T2 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
DE3872199T2
DE3872199T2 DE8888202909T DE3872199T DE3872199T2 DE 3872199 T2 DE3872199 T2 DE 3872199T2 DE 8888202909 T DE8888202909 T DE 8888202909T DE 3872199 T DE3872199 T DE 3872199T DE 3872199 T2 DE3872199 T2 DE 3872199T2
Authority
DE
Germany
Prior art keywords
glycerol
cimetidine
ester
weight
hydroxyl value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888202909T
Other languages
German (de)
English (en)
Other versions
DE3872199D1 (de
Inventor
Eberhard Fritz Gottwald
Horst Manfred Machoczek
David Mayron
Hermann Peter Osterwald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Dauelsberg GmbH
Original Assignee
SmithKline Dauelsberg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Dauelsberg GmbH filed Critical SmithKline Dauelsberg GmbH
Publication of DE3872199D1 publication Critical patent/DE3872199D1/de
Application granted granted Critical
Publication of DE3872199T2 publication Critical patent/DE3872199T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888202909T 1987-12-23 1988-12-16 Pharmazeutische zusammensetzungen. Expired - Lifetime DE3872199T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730011A GB8730011D0 (en) 1987-12-23 1987-12-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE3872199D1 DE3872199D1 (de) 1992-07-23
DE3872199T2 true DE3872199T2 (de) 1992-12-17

Family

ID=10628958

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888202909T Expired - Lifetime DE3872199T2 (de) 1987-12-23 1988-12-16 Pharmazeutische zusammensetzungen.

Country Status (15)

Country Link
US (1) US5057319A (cg-RX-API-DMAC10.html)
EP (1) EP0322048B1 (cg-RX-API-DMAC10.html)
JP (1) JP2840097B2 (cg-RX-API-DMAC10.html)
AT (1) ATE77236T1 (cg-RX-API-DMAC10.html)
AU (1) AU605671B2 (cg-RX-API-DMAC10.html)
CA (1) CA1313140C (cg-RX-API-DMAC10.html)
DE (1) DE3872199T2 (cg-RX-API-DMAC10.html)
DK (1) DK415689D0 (cg-RX-API-DMAC10.html)
ES (1) ES2042723T3 (cg-RX-API-DMAC10.html)
GB (1) GB8730011D0 (cg-RX-API-DMAC10.html)
GR (1) GR3005640T3 (cg-RX-API-DMAC10.html)
IE (1) IE60966B1 (cg-RX-API-DMAC10.html)
PT (1) PT89260B (cg-RX-API-DMAC10.html)
WO (1) WO1989005640A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA889441B (cg-RX-API-DMAC10.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578322A (en) * 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
EP0663818A4 (en) * 1992-09-03 1996-04-24 Ibah Inc TASTE-COVERING PHARMACEUTICAL SUMMARY AND METHOD FOR PRODUCING THE SAME.
AU669952B2 (en) * 1992-10-16 1996-06-27 Glaxo Group Limited Taste-masking compositions of ranitidine
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
KR0168715B1 (ko) * 1992-11-30 1999-01-15 밋첼 아이. 커시너 맛을 차단하는 약제학적 조성물
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
JP3601071B2 (ja) * 1994-03-11 2004-12-15 不二製油株式会社 ブルーム防止剤並びにこれを含有するラウリン系油脂及びチョコレート類
AUPN862596A0 (en) * 1996-03-12 1996-04-04 F.H. Faulding & Co. Limited Pharmaceutical compositions
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
EP1020193A4 (en) * 1997-09-30 2006-05-24 Daiichi Seiyaku Co ORAL PREPARATION
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7510728B2 (en) 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
CA2664315C (en) * 2006-09-15 2016-01-19 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2008033023A2 (en) * 2006-09-15 2008-03-20 Echo Pharmaceuticals B.V. Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド 17−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296B1 (en) 2018-07-20 2026-04-01 Lipocine Inc. Oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
JPS6029682B2 (ja) * 1980-07-11 1985-07-12 山之内製薬株式会社 苦味のない製剤用組成物およびその製造法
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB2195890A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
US4786502A (en) * 1986-10-06 1988-11-22 The Procter & Gamble Company Palatable solid pharmaceutical compositions
GB2195891A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
US4892778A (en) * 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.

Also Published As

Publication number Publication date
CA1313140C (en) 1993-01-26
EP0322048A1 (en) 1989-06-28
WO1989005640A1 (en) 1989-06-29
IE883843L (en) 1989-06-23
ATE77236T1 (de) 1992-07-15
DK415689A (da) 1989-08-23
GR3005640T3 (cg-RX-API-DMAC10.html) 1993-06-07
IE60966B1 (en) 1994-09-07
ZA889441B (en) 1989-12-27
ES2042723T3 (es) 1993-12-16
DE3872199D1 (de) 1992-07-23
JPH02502729A (ja) 1990-08-30
AU605671B2 (en) 1991-01-17
PT89260A (pt) 1989-12-29
GB8730011D0 (en) 1988-02-03
JP2840097B2 (ja) 1998-12-24
PT89260B (pt) 1993-07-30
AU2915789A (en) 1989-07-19
EP0322048B1 (en) 1992-06-17
US5057319A (en) 1991-10-15
DK415689D0 (da) 1989-08-23

Similar Documents

Publication Publication Date Title
EP0322048B1 (en) Pharmaceutical compositions
DE69629797T2 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
DE69933689T2 (de) Verfahren zur herstellung von oralen calcium zusammensetzungen
DE68904459T2 (de) Antacidzusammensetzungen mit laengerer verweilzeit im magen.
DE69802543T2 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE3780222T2 (de) Pharmazeutische zusammensetzung mit kontrollierter wirkstofffreisetzung.
DE69233130T2 (de) Kaubare zusammensetzung zur arzneimittelfreisetzung
DE3879286T2 (de) Fluessige dispersion zur oralen verabreichung.
DE69717312T2 (de) Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden
DE3587274T2 (de) Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
AT392901B (de) Verfahren zur herstellung einer granulaeren form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
DE69025150T2 (de) Pharmazeutische Lutschpastillen
DE69013296T3 (de) Einzeldosen mit verzögerter Arzneistofffreigabe.
DE69901938T2 (de) Schnell zerfallende tablette
DE69514192T2 (de) Arzneimittel und/oder Nahrungsmikrokapseln zur oralen Verabreichung
DE69811233T2 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE60128215T2 (de) Beschichtungszusammensetzung zur geschmacksmaskierung
DE68915695T2 (de) Zubereitungen mit kontrollierter Wirkstoffabgabe.
EP0068191B1 (de) Orale Dipyridamolformen
DE69324214T2 (de) Pharmazeutische flüssige Suspensionszusammensetzung mit kontrollierter Freigabe
CH630257A5 (en) Sustained release formulation
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE3719818A1 (de) Pharmazeutische zusammensetzungen
DE60319802T2 (de) Sedierende nicht-benzodiazepin-formulierungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition